.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Merck
Medtronic
Fish and Richardson
Novartis
McKinsey
Deloitte
Dow
Federal Trade Commission
Mallinckrodt

Generated: June 26, 2017

DrugPatentWatch Database Preview

GENGRAF Drug Profile

« Back to Dashboard

What is the patent landscape for Gengraf, and what generic Gengraf alternatives are available?

Gengraf is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in GENGRAF is cyclosporine. There are seventeen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.

Summary for Tradename: GENGRAF

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list77
Clinical Trials: see list7
Patent Applications: see list9,700
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GENGRAF at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
GENGRAF
cyclosporine
CAPSULE;ORAL065003-001May 12, 2000AB1RXNoNo► Subscribe► Subscribe
Abbvie
GENGRAF
cyclosporine
CAPSULE;ORAL065003-002May 12, 2000AB1RXNoNo► Subscribe► Subscribe
Abbvie
GENGRAF
cyclosporine
CAPSULE;ORAL065003-003May 12, 2000AB1RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Harvard Business School
Queensland Health
Boehringer Ingelheim
Cipla
Covington
Healthtrust
Deloitte
Chubb
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot